Get the Stockscreener App
3.39
10.55%
-0.40
Pre-market:
3.22
-0.17
-5.01%
Onconetix Inc stock is traded at $3.39, with a volume of 40,154.
It is down -10.55% in the last 24 hours and up +9.00% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
See More
Previous Close:
$3.79
Open:
$3.61
24h Volume:
40,154
Relative Volume:
0.08
Market Cap:
$5.24M
Revenue:
-
Net Income/Loss:
$-53.12M
P/E Ratio:
-0.0312
EPS:
-108.8
Net Cash Flow:
$-15.86M
1W Performance:
-3.97%
1M Performance:
+9.00%
6M Performance:
-45.44%
1Y Performance:
-98.62%
1-Day Range:
$3.38
$3.73
1-Week Range:
$3.38
$4.00
52-Week Range:
$2.45
$257.99
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
3.39 | 5.89M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Onconetix Inc Stock (ONCO) Latest News
What’s the recovery path for long term holders of Onconetix Inc.Weekly Loss Report & Reliable Intraday Trade Plans - newser.com
Is Onconetix Inc. (J4T) stock a defensive play amid uncertaintyPortfolio Return Summary & Detailed Earnings Play Alerts - newser.com
Is Onconetix Inc. (J4T) stock worth holding before Fed meeting2025 Market Overview & AI Enhanced Execution Alerts - newser.com
Analyzing net buyer seller activity in Onconetix Inc.Market Risk Analysis & Consistent Profit Trading Strategies - newser.com
Why Onconetix Inc. stock is considered a top pick2025 Fundamental Recap & Verified Short-Term Plans - newser.com
Is Onconetix Inc. stock a smart buy before Fed meetingRate Cut & High Win Rate Trade Tips - newser.com
Will Onconetix Inc. stock maintain momentum in 20252025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
What analysts say about Onconetix Inc stockStock Market Trends & Let Our AI Be Your Trading Assistant - earlytimes.in
Tools to assess Onconetix Inc.’s risk profile2025 Market Overview & Low Risk Growth Stock Ideas - newser.com
Real time social sentiment graph for Onconetix Inc.Weekly Profit Summary & Low Risk High Win Rate Picks - newser.com
Can technical indicators confirm Onconetix Inc.’s reversalRisk Management & Verified Short-Term Trading Plans - newser.com
How to forecast Onconetix Inc. trends using time seriesJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - newser.com
What Fibonacci levels say about Onconetix Inc. reboundJuly 2025 Highlights & Fast Moving Market Watchlists - newser.com
Is Onconetix Inc. (J4T) stock nearing a technical breakout2025 Momentum Check & High Accuracy Swing Trade Signals - newser.com
Will Onconetix Inc. (J4T) stock announce special dividendJuly 2025 Opening Moves & Expert Curated Trade Setups - newser.com
Order flow analysis tools used on Onconetix Inc.Portfolio Return Report & Growth-Oriented Investment Plans - newser.com
Why analysts upgrade Onconetix Inc. stockMarket Risk Summary & Daily Market Momentum Tracking - newser.com
How Onconetix Inc. (J4T) stock trades after rate cutsTrade Entry Summary & Low Risk Entry Point Tips - newser.com
Onconetix Announces 2025 Annual Meeting Details - The Globe and Mail
Is Onconetix Inc. stock reversal real or fakeJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
Is Onconetix Inc. stock poised for growthProduct Launch & Weekly High Conviction Ideas - newser.com
Using Bollinger Bands to evaluate Onconetix Inc.2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Is Onconetix Inc. stock a safe investment in uncertain markets2025 Winners & Losers & Low Risk Investment Opportunities - newser.com
What drives Onconetix Inc stock priceEnergy Sector Updates & Free Explosive Return Secrets - earlytimes.in
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):